Giwercman A, Kledal T, Schwartz M, Giwercman Y L, Leffers H, Zazzi H, Wedell A, Skakkebaek N E
University Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark.
J Clin Endocrinol Metab. 2000 Jun;85(6):2253-9. doi: 10.1210/jcem.85.6.6626.
Mutations in the androgen receptor gene are considered as incompatible with preservation of fertility and have been suggested as a cause of male infertility. Two adult brothers, referred because of gynecomastia and hormonal levels in serum indicating androgen insensitivity (high sex hormone-binding globulin, and LH levels, despite extremely high testosterone concentration), turned out to be relatives to a third young man, referred independently of the two others and exhibiting identical clinical and hormonal stigmata. In all three men, we found a C-->A substitution at position 2470 (exon 7) in the androgen receptor gene, leading to a Gln824Lys mutation in the ligand-binding domain of the receptor. Exploring the family history revealed that their grandfathers, on their mothers' side, were brothers; and the Gln824Lys mutation was also found in the one of them who was still alive. Binding studies with the mutant receptor in transfected COS-7 cells, with mibolerone as ligand, exhibited equal Kd (0.7 vs. 1.0 nmol/ L), IC50 (0.8 vs. 1.1 nmol/L), and maximum binding (7.1 vs. 8.9 fmol/ 10(6) cells), as compared with the wild-type (WT) receptor. In a chloramphenicol acetyl transferase trans-activation assay, the activity of the mutant receptor was identical to that of the WT, when the synthetic androgen R1881 was'used as a ligand; but with dihydrotestosterone, in concentrations up to 10 nmol/L, the activity of Gln824Lys mutated receptor was 10-62% of the WT variant. Thus, Gln824Lys mutation was found, both in vivo and in vitro, to cause slight impairment of receptor function but was compatible with preservation of male fertility. The patients inherited the mutation from their grandfathers through their mothers, and one of the young men possessing the mutation has fathered a daughter.
雄激素受体基因突变被认为与生育力的保留不相容,并被认为是男性不育的一个原因。两名成年兄弟因乳腺增生和血清激素水平提示雄激素不敏感(高性激素结合球蛋白和促黄体生成素水平,尽管睾酮浓度极高)前来就诊,结果发现他们与另一名独立前来就诊的年轻男子有亲属关系,该年轻男子表现出相同的临床和激素特征。在这三名男性中,我们在雄激素受体基因的第2470位(外显子7)发现了C→A替换,导致受体配体结合域中的Gln824Lys突变。对家族史的调查显示,他们的外祖父是亲兄弟,且在仍在世的其中一位外祖父中也发现了Gln824Lys突变。以米勃龙为配体,在转染的COS-7细胞中对突变受体进行结合研究,结果显示与野生型(WT)受体相比,其解离常数(Kd)(0.7对1.0 nmol/L)、半数抑制浓度(IC50)(0.8对1.1 nmol/L)和最大结合量(7.1对8.9 fmol/10(6)细胞)均相同。在氯霉素乙酰转移酶转激活试验中,当使用合成雄激素R1881作为配体时,突变受体的活性与野生型相同;但使用二氢睾酮时,在浓度高达10 nmol/L的情况下,Gln824Lys突变受体的活性仅为野生型变体的10%-62%。因此,无论是在体内还是体外,均发现Gln824Lys突变会导致受体功能略有受损,但与男性生育力的保留是相容的。这些患者通过母亲从外祖父那里遗传了该突变,其中一名携带该突变的年轻男子已育有一女。